From palliation to cure: PIPAC for peritoneal malignancies

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 5%
• Aerosol 38%
• Base 5%
• Carcinomatous Peritonitis 5%
• Chemotherapy 100%
• Death 5%
• Diseases 5%
• Neoplasm 5%
• Peritoneal Disease 5%

Medicine and Dentistry

• Abdominal Cavity 5%
• Adverse Event 5%
• Base 5%
• Cancer 5%
• Carcinomatous Peritonitis 5%
• Diseases 5%
• Drug Bioavailability 5%
• Intraperitoneal Drug Administration 5%
• Meta-Analysis 11%
• Neoplasm 5%
• Patient 11%
• Peritoneal Disease 5%
• Symptomatic Treatment 5%
• Systematic Review 5%